Japan medicine information and human support for international patients.
Japan
Wegovy Japan information page
Wegovy in Japan: semaglutide injection strengths, eligibility context, and request checks.
Wegovy is a Japanese prescription semaglutide injection with strict medical-use context. This page helps international visitors identify Japanese product wording, pen and SD formats, strengths, storage requirements, and the information support needs before follow-up.
Contact support with product detailsWhat “Wegovy in Japan” means
Here, “Japan” refers to the Japanese prescription-medicine information environment: Japanese brand wording, approved-use context, package format, strength names, storage requirements, and the confirmation points support needs before any manual follow-up.
Wegovy should not be treated as a casual online weight-loss product. Japanese medical use is subject to professional assessment and strict criteria. This page is for product identification, not eligibility judgment or dosing advice.
Japanese name and product wording
ウゴービ
The Japanese brand name for Wegovy.
皮下注
Subcutaneous injection. Storage and route planning can matter.
セマグルチド
Semaglutide, the active ingredient also seen in Ozempic and Rybelsus.
Strengths and formats to confirm
Japanese PMDA listings include both SD and pen-format Wegovy product names. A request should identify the exact format, strength, quantity, and destination country.
| Japanese format | Strength names commonly listed | What support checks |
|---|---|---|
| Wegovy SD / ウゴービ皮下注 SD | 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg | Whether the requested SD format is current, available, and practical for destination-country handling. |
| Wegovy pen / ウゴービ皮下注ペン | 0.25 mg pen 1.0MD, 0.5 mg pen 2.0MD, 1.0 mg pen 4.0MD, 1.7 mg pen 6.8MD, 2.4 mg pen 9.6MD | Exact pen listing, quantity, use context, storage, and import-route feasibility. |
| Ingredient | Semaglutide / セマグルチド | Whether the request is truly for Wegovy, not Ozempic injection or Rybelsus tablets. |
Medical-use context
Japanese official information identifies Wegovy as semaglutide and lists it as a prescription medicine used under medical supervision. Japanese healthcare discussions around Wegovy include strict appropriate-use conditions, so support should collect medical-review context rather than only product name and price.
MedGuide Japan does not decide whether Wegovy is appropriate for a person, does not select a dose, and does not replace a clinician. Eligibility and use must be assessed by qualified healthcare professionals.
Wegovy vs Ozempic vs Rybelsus
| Product | Shared point | Key difference to avoid confusion |
|---|---|---|
| Wegovy | Semaglutide | Japanese prescription injection with strict obesity-related medical-use context. |
| Ozempic | Semaglutide | Injectable product listed in Japan for type 2 diabetes. |
| Rybelsus | Semaglutide | Oral tablet. Administration timing and tablet count are central. |
Safety points to mention before requesting
Tell your physician and support staff if any of the following are relevant:
- Diabetes, insulin use, sulfonylurea use, or history of low blood sugar.
- History of pancreatitis, gallbladder disease, or severe gastrointestinal disorder.
- Pregnancy, breastfeeding, or planning pregnancy.
- Current or recent use of Ozempic, Rybelsus, Mounjaro, or another GLP-1 medicine.
- Severe infection, surgery, or another urgent medical situation.
- Any previous allergy or serious reaction to semaglutide or injection products.
Cold-chain and shipment questions
Wegovy is an injection product with temperature-sensitive handling. Before any follow-up, support needs destination country, quantity, signing availability, expected route, seasonal temperature risk, and whether cold-chain packaging is practical.
Request checklist
- Exact product name: Wegovy / ウゴービ皮下注.
- Format: SD or pen, if known.
- Strength: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg.
- Quantity or number of pens/kits.
- Destination country or region.
- Whether you are starting, continuing, or switching from another GLP-1 product.
- Whether you are starting, continuing, or switching from another GLP-1 medicine.
- Any product photo, clinic instruction, or Japanese listing you want support to check.
Wegovy Japan FAQ
Is Wegovy Japan the same as semaglutide?
Wegovy is the brand name. Semaglutide is the active ingredient, also seen in Ozempic and Rybelsus.
Is Wegovy the same as Ozempic?
No. Both contain semaglutide, but they are different Japanese products with different strengths and medical-use context.
What format should I mention?
State whether the request is for SD or pen format if known, plus strength and quantity.
Can support judge eligibility?
No. Eligibility and use must be assessed by qualified healthcare professionals. Support can help organize product-identification details.
Why is cold-chain context required?
Wegovy is an injectable product. Destination, route, signing availability, and temperature risk can affect feasibility.
What should I send first?
Send format, strength, quantity, destination country, cold-chain context, and whether you are switching from another GLP-1 product.
Related GLP-1 pages
GLP-1 comparison guide
Compare Mounjaro, Ozempic, Wegovy, and Rybelsus in Japan.
Ozempic Japan
Semaglutide injection page for visitors comparing Ozempic and Wegovy.
Contact checklist
Send format, strength, quantity, destination, cold-chain context, and GLP-1 use context.
Ask support with complete Wegovy details.
Use the contact page to send the Wegovy format, strength, quantity, destination country, cold-chain context, and GLP-1 use context.
Contact supportMedGuide Japan provides product-information support only. We do not diagnose, choose doses, replace medical advice, or guarantee availability.